FLINT, Mich. — Diplomat Pharmacy Inc. has acquired Burman’s Specialty Pharmacy in an $82.8 million deal.

Burman’s, based in Pennsylvania, is a provider of individualized patient care with a primary focus on hepatitis C.

“Burman’s shares our strong commitment to patient care,” said Diplomat chairman and chief executive officer Phil Hagerman. “We acquired Burman’s to enhance our targeted clinical management programs, utilize its innovative hepatitis C technology platform and strong payor network, and increase our presence in the U.S. Mid-Atlantic region.”

Burman’s enhances therapy management through its proprietary software platform HealthTrac, specifically designed to navigate the complexities of hepatitis C therapy and allow pharmacists and providers to collaborate on patient care.

Hagerman said that the HealthTrac technology will significantly expand Diplomat’s hepatitis C services across its national footprint.

“Diplomat’s patient-centric focus echoes our own approach,” said Steve Burman, president and CEO of Burman’s.